XTL Biopharmaceuticals Ltd. (XTLB)
Develops drugs to treat autoimmune diseases like lupus and Sjogren's syndrome.
$2.96+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-46.8%
The outlook
XTLB is trading near its 52-week lows, sitting just 11% of the way up from its yearly bottom. The stock shows mixed momentum against its moving averages, and analyst sentiment is leaning bearish overall. Today's modest movement offers no clear directional signal.
What’s behind the score
Price trendMixed vs its moving averages
52-week range11% of the way from its 52-week low to high
Market cap
$7.3M
52-wk high
$10.28
52-wk low
$2.01
50-day avg
$2.61
200-day avg
$3.17
Trailing P/E
—